Evidence map›Paper›PMID 23845626›Full record

ArticleJournal of pediatric surgery2013

Synergistic effects of HB-EGF and mesenchymal stem cells in a murine model of intestinal ischemia/reperfusion injury.

Daniel J Watkins, Jixin Yang, Mika A B Matthews, Gail E Besner

Abstract readEvaluation Study
In one paragraph

Article in Journal of pediatric surgery, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Hydrogen sulfide improves intestinal recovery following ischemia by endothelial nitric oxide-dependent mechanisms.American journal of physiology. Gastrointestinal and liver physiology · 2017
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel J WatkinsThe Research Institute at Nationwide Children's Hospital, Center for Perinatal Research, Columbus, OH 43205, USA.
Jixin Yang
Mika A B Matthews
Gail E Besner

Funding

HB-EGF and Intestinal Ischemia/ReperfusionR01GM061193 · NIGMS · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BESNER, GAIL E · 2002 to 2014
$3.6M
Role of NO and Endothelin in Human NECR01DK065306 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BESNER, GAIL E. · 2003 to 2007
$1.6M
HB-EGF Therapy for Necrotizing EntercolitisR01DK074611 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BESNER, GAIL E · 2007 to 2011
$1.4M
NIDDK NIH HHS R01 DK065306NIDDK NIH HHS R01 DK074611NIGMS NIH HHS R01 GM061193NIGMS NIH HHS R01 GM61193
6 · The paper itself

Abstract

backgroundWe have previously demonstrated that heparin-binding EGF-like growth factor (HB-EGF) administration protects the intestines from ischemia/reperfusion (I/R) injury in vivo. We have also shown that HB-EGF promotes mesenchymal stem cell (MSC) proliferation and migration in vitro. The goals of the current study were to examine the effects of HB-EGF and both bone marrow (BM)- and amniotic fluid (AF)-derived MSC on intestinal I/R injury in vivo. MATERIALS AND

methodsMSC were isolated from pan-EGFP mice, expanded, and purified. Pluripotency was confirmed by induced differentiation. Mice were subjected to terminal ileum I/R and received either: (1) no therapy; (2) HB-EGF; (3) BM-MSC; (4) HB-EGF+BM-MSC; (5) AF-MSC; or (6) HB-EGF+AF-MSC. MSC engraftment, histologic injury, and intestinal permeability were quantified.

resultsThere was increased MSC engraftment into injured compared to uninjured intestine for all experimental groups, with significantly increased engraftment for AF-MSC+HB-EGF compared to AF-MSC alone. Administration of HB-EGF and MSC improved intestinal histology and intestinal permeability after I/R injury. The greatest improvement was with combined administration of HB-EGF+AF-MSC.

conclusionsBoth HB-EGF alone and MSC alone can protect the intestines from I/R injury, with synergistic efficacy occurring when HB-EGF and AF-MSC are administered together.

Indexed as

Intestine, SmallMesenchymal Stem Cell TransplantationAmniotic FluidAnimalsBone Marrow CellsCombined Modality TherapyFemaleGastrointestinal AgentsHeparin-binding EGF-like Growth FactorIntercellular Signaling Peptides and ProteinsMaleMiceMice, Inbred C57BLProtective AgentsRandom AllocationReperfusion InjuryGastrointestinal AgentsHbegf protein, mouseHeparin-binding EGF-like Growth FactorIntercellular Signaling Peptides and ProteinsProtective AgentsAmniotic fluidBone marrowHeparin-binding EGF-like growth factorIntestinal injuryIschemia/reperfusionMesenchymal stem cells

Identifiers

PMID23845626
PMCPMC3710437

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.